Breast cancer screening legislation in the United States.
Breast cancer screening legislation in the United States.
复制标题
美国乳腺癌筛查立法。
DOI：
10.2105/ajph.79.11.1541
复制
发表时间：
1989
影响因子：
12.7
通讯作者：
L. Boss
中科院分区：
文献类型：
--
作者：
G. B. Thompson;L. Kessler;L. Boss
我们讨论了过去三年来在预防服务方面强有力的立法运动中出现的一些问题。在此期间，越来越多的州通过、考虑或正在制定乳腺癌筛查立法。这些法律大多要求某种形式的第三方支付乳房x光检查或建立乳腺癌筛查项目。在检查的周期、覆盖的年龄、第三方覆盖的类型和范围、剂量规定和放射设备标准方面，立法有很大的不同。这表明需要通用标准。立法为公共卫生应对严重问题提供了必要的激励，但需要的不仅仅是法律。卫生保健提供者和一般公众需要了解并利用立法提供的覆盖范围。此外，公共卫生官员需要认识到，这种立法可能导致对服务的需求超过目前提供服务的能力。
We discuss some of the issues emerging from a powerful legislative movement for preventive services over the past three years. During this time an increasing number of states passed, considered, or are currently developing breast cancer screening legislation. Most of these laws require some form of third party payment for mammography or establish breast cancer screening programs. The legislation varies markedly with regard to periodicity of examinations, ages covered, type and extent of third party coverage, dosage regulation, and radiographic equipment standards. This shows a need for common standards. Legislation provides an essential incentive for a public health response to a serious problem, but more than laws are needed. Health care providers and the general public need to be aware and take advantage of the coverage provided as a result of legislation. Moreover, public health officials need to be aware that such legislation may lead to a demand for services that exceeds present capacity to deliver them.